Feedback Share Discussion Threads

[petekand] 27/11/2021 20:40

Cheap and cheerful never let me down although they also do one which has your picture.



Regarding the eye problem, you may not be alone as the government own figures show over 20,000 reports of adverse reactions concerning the eyes and including total blindness following on from the jab.

[ragnarr] 27/11/2021 19:14

Quote. Technology is a word that describes something that doesn't work yet :-)

[petekand] 27/11/2021 18:49

Rag, I don’t remember making a mention of religion, politics or any conspiracy theory but only a few verifiable facts.

Anyhow, seeing the price at 1.2p and after that interview, I applied for 1.75 million of these on top of my full entitlement so it will be interesting to see how many they allocate. I too expect some good newsflow as the diagnostic hubs gain traction.

With that ugly predator looking thing very mysteriously turning up on our shores in record time, one would assume there will be a renewed urgency to get these hubs into operation. Bleepa may well greatly benefit from this nonsense.

Right, need to find and take the dust off that mask exemption card which served me so well.

[lr2] 27/11/2021 18:38

Missed the storm completely here in the Chilterns and didn't even hear anything about it today.

The tweaking is a blight on producing solid IT products, it almost always results from management not knowing precisely what their customers want and the IT team not having enough access to the people who will be using the finished product. Good to see that the same IT problems are still doing the rounds 20+ years after I finished worrying about them.

[yump] 27/11/2021 18:31

Well, I'm still looking forward to the announcement flow.

There's no doubt that the NHS needs both Bleepa and Carelocker.

[ged5] 27/11/2021 18:18

Ha,ha.

True Manc here so much so I moved to Merseyside!

Close to 70mph winds overnight. Lost 3 fence panels and part of the shed but OK. Thanks for asking. Everything fixed on Monday.

Remember you saying about the tweaking, Yump but it seems to have happened more or less from the start. The RNS talks about development in a few places even with Bleepa.

[lr2] 27/11/2021 18:14

The two do go together don't they?

[chopper harris1] 27/11/2021 18:00

There was me thinking that Ged must live in Surrey as he's a Man Utd fan.

[lr2] 27/11/2021 17:57

First thing Monday then.

Also, and off topic, what storm Ged (hope you are OK) plus I see Omicron has arrived on our shores.

[ducatiman] 27/11/2021 17:43

Looking forward to a pre AGM statement.

[ged5] 27/11/2021 15:36

No fooling some. Unbelievable!

Anyway, after almost a month of silence the AGM 11:00 on Monday should at least enlighten us about how many excess shares we might receive. I can't see the resolutions not being passed.

Then we should receive our entitlement on Tuesday.

After that I'm hoping for the MOU with Qure.AI and Quest Teleradiology to be signed off.

Good point Yump about Carelocker. Reading through the placing RNS it does look as if it is still in the development stage.

Everyone OK after the storm last night?

[yump] 27/11/2021 15:29

Ragnarr

I think mood only affects about 10% of my view here.

Its when I listened to the interview in the cold light of day that my view changed for the worse as I realised that the interview had made me overly optimistic, based on something not as material as I thought.

[ragnarr] 27/11/2021 12:40

Ona light note, the old adage that you never know whats round the corner couldnt be more true..One minute you are a company named from a letter in the Greek alphabet - next you are a Covid variant. Unfortunate. :-(.https://www.omicronenergy.com

[ragnarr] 27/11/2021 12:40

Please lets keep it Stock related - Religion, politics, and conspiracy theories dont belong here.

[ragnarr] 27/11/2021 10:06

Are you in a better mood this morning :-)

[yump] 27/11/2021 09:29

At least there should be plenty of newsflow, whether material or not.

[yump] 26/11/2021 21:19

I wonder what TO actually implemented as part of the entreprenerial job in the NHS ? Or was it an exploration/report back type appointment ?

Only being a CEO in a small company is an implementation role, so I’d hope that when he was appointed, the appropriate questions were asked.

I noted a comment from an interviewer in the Sunday Roast interview that “doctors don’t like numbers”, just before asking about likely revenue.

Lets hope this one does - especially those of the business. Clearly having an unspecified or vague number for remuneration wasn’t in the agenda.

Just imagine...

“Well people doing your job could earn up to £200K annually”. “So what salary are you offering ?”. “Well I wouldn’t be surprised if you had the potential to earn far more than that”. “Yes, but what is it?”.........

[lr2] 26/11/2021 20:57

Thanks Chopper, hope you are keeping well. This latest Covid variant is likely going to be a real problem once it reaches these shores. The previous Delta variant had two mutations over the Alpha variant and took the world by storm, becoming the overwhelming cause of most Covid cases. This new variant over 50 mutations and 32 of them in the spike protein. The human body is very unlikely to be able to fight off all the ways in which the latest variant, I believe they plan on calling it Omicron, can attack it.

Tulio de Olivera, Director of CERI, the Centre for Epidemic Response & innovation in South Africa said on twitter yesterday that "This new variant, B.1.1.529 seems to spread very quick! In less than 2 weeks now dominates all infections following a devastating Delta wave in South Africa."

I'd be surprised if the government did not apply another lockdown once it gets to the UK. They will not want to be blamed for doing nothing if it is even more virulent than the previous variants.

[chopper harris1] 26/11/2021 19:39

Hope you end up quaffing copious amounts of rum in celebration of Bleepa’s success, LR2...I may even join you with a glass or two of babycham.

My opinion on the other subject of Covid: there won’t/can̵7;t be another lockdown because there will be no more furlough money to support affected businesses and a vast swathe of the population have had enough and will just ignore any more draconian restrictions.

We’ve just got to get on with it now and treat Covid like we’ve always treated influenza and the common cold. Nothing stopping those that consider themselves to be especially vulnerable or are still anxious about Covid from shielding themselves for as long as they deem necessary. But don’t destroy the economy any further.

Agree strongly with regular intake of Vitamin D supplements. I think it’s a great pity that all the scaremongering scientists and doctors wheeled out over the past couple of years have never properly promoted and encouraged this very simple and cost-effective method of boosting our immunity to many illnesses, including Covid.

[ragnarr] 26/11/2021 18:28

Well the institutions that took up the over subscribed placing were perfectly happy with the explanation they were given :-) Feedback plc (AIM: FDBK), the specialist clinical communication company, is pleased to announce the completion of the Bookbuild announced earlier today, which was oversubscribed. A total of 1,528,571,420 Placing Shares have been conditionally placed at the Issue Price of 0.7 pence per Placing Share to raise a total of approximately GBP10.7 million for the Company (before expenses).The Company also announced details of an Open Offer to be made to Qualifying Shareholders to raise up to an additional GBP0.5 million at the Issue Price.The net proceeds of the Fundraising will be used primarily to:-- further develop the "CareLocker - powered by Bleepa" product to meet existing and growing demand in both the UK and international markets;-- further develop Bleepa in order to grow its functionality, including features for non-healthcare customers such as veterinary professionals;-- build upon the existing UK team in order to accelerate revenue growth in the UK and to manage overseas operations, which requires increased resources for the marketing, sales, finance and regulatory teams, and-- undertake a tuberculosis screening pilot study in India and explore wider market opportunities and potential applications of the Company's technology in India.